Pediatric Drugs and Vaccines-Europe Market Status and Trend Report 2013-2023
Report Summary
Pediatric Drugs and Vaccines-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pediatric Drugs and Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pediatric Drugs and Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pediatric Drugs and Vaccines in Europe, with company and product introduction, position in the Pediatric Drugs and Vaccines market
Market status and development trend of Pediatric Drugs and Vaccines by types and applications
Cost and profit status of Pediatric Drugs and Vaccines, and marketing status
Market growth drivers and challenges
The report segments the Europe Pediatric Drugs and Vaccines market as:
Europe Pediatric Drugs and Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pediatric Drugs and Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Europe Pediatric Drugs and Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Newborn
Infant
Child
Europe Pediatric Drugs and Vaccines Market: Players Segment Analysis (Company and Product introduction, Pediatric Drugs and Vaccines Sales Volume, Revenue, Price and Gross Margin):
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pediatric Drugs and Vaccines-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pediatric Drugs and Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pediatric Drugs and Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pediatric Drugs and Vaccines in Europe, with company and product introduction, position in the Pediatric Drugs and Vaccines market
Market status and development trend of Pediatric Drugs and Vaccines by types and applications
Cost and profit status of Pediatric Drugs and Vaccines, and marketing status
Market growth drivers and challenges
The report segments the Europe Pediatric Drugs and Vaccines market as:
Europe Pediatric Drugs and Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pediatric Drugs and Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Europe Pediatric Drugs and Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Newborn
Infant
Child
Europe Pediatric Drugs and Vaccines Market: Players Segment Analysis (Company and Product introduction, Pediatric Drugs and Vaccines Sales Volume, Revenue, Price and Gross Margin):
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PEDIATRIC DRUGS AND VACCINES
1.1 Definition of Pediatric Drugs and Vaccines in This Report
1.2 Commercial Types of Pediatric Drugs and Vaccines
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Mumps
1.2.7 Others
1.3 Downstream Application of Pediatric Drugs and Vaccines
1.3.1 Newborn
1.3.2 Infant
1.3.3 Child
1.4 Development History of Pediatric Drugs and Vaccines
1.5 Market Status and Trend of Pediatric Drugs and Vaccines 2013-2023
1.5.1 Europe Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pediatric Drugs and Vaccines in Europe 2013-2017
2.2 Consumption Market of Pediatric Drugs and Vaccines in Europe by Regions
2.2.1 Consumption Volume of Pediatric Drugs and Vaccines in Europe by Regions
2.2.2 Revenue of Pediatric Drugs and Vaccines in Europe by Regions
2.3 Market Analysis of Pediatric Drugs and Vaccines in Europe by Regions
2.3.1 Market Analysis of Pediatric Drugs and Vaccines in Germany 2013-2017
2.3.2 Market Analysis of Pediatric Drugs and Vaccines in United Kingdom 2013-2017
2.3.3 Market Analysis of Pediatric Drugs and Vaccines in France 2013-2017
2.3.4 Market Analysis of Pediatric Drugs and Vaccines in Italy 2013-2017
2.3.5 Market Analysis of Pediatric Drugs and Vaccines in Spain 2013-2017
2.3.6 Market Analysis of Pediatric Drugs and Vaccines in Benelux 2013-2017
2.3.7 Market Analysis of Pediatric Drugs and Vaccines in Russia 2013-2017
2.4 Market Development Forecast of Pediatric Drugs and Vaccines in Europe 2018-2023
2.4.1 Market Development Forecast of Pediatric Drugs and Vaccines in Europe 2018-2023
2.4.2 Market Development Forecast of Pediatric Drugs and Vaccines by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pediatric Drugs and Vaccines in Europe by Types
3.1.2 Revenue of Pediatric Drugs and Vaccines in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pediatric Drugs and Vaccines in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pediatric Drugs and Vaccines in Europe by Downstream Industry
4.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Germany
4.2.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in France
4.2.4 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Italy
4.2.5 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Spain
4.2.6 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Benelux
4.2.7 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Russia
4.3 Market Forecast of Pediatric Drugs and Vaccines in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
5.1 Europe Economy Situation and Trend Overview
5.2 Pediatric Drugs and Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PEDIATRIC DRUGS AND VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pediatric Drugs and Vaccines in Europe by Major Players
6.2 Revenue of Pediatric Drugs and Vaccines in Europe by Major Players
6.3 Basic Information of Pediatric Drugs and Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pediatric Drugs and Vaccines Major Players
6.3.2 Employees and Revenue Level of Pediatric Drugs and Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PEDIATRIC DRUGS AND VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck & Co., Inc. (USA)
7.1.1 Company profile
7.1.2 Representative Pediatric Drugs and Vaccines Product
7.1.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. (USA)
7.2 Abbott Laboratories (USA)
7.2.1 Company profile
7.2.2 Representative Pediatric Drugs and Vaccines Product
7.2.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Abbott Laboratories (USA)
7.3 Amgen, Inc. (USA)
7.3.1 Company profile
7.3.2 Representative Pediatric Drugs and Vaccines Product
7.3.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Amgen, Inc. (USA)
7.4 Eli Lilly and Company (USA)
7.4.1 Company profile
7.4.2 Representative Pediatric Drugs and Vaccines Product
7.4.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly and Company (USA)
7.5 F. Hoffmann-La Roche Ltd (Switzerland)
7.5.1 Company profile
7.5.2 Representative Pediatric Drugs and Vaccines Product
7.5.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd (Switzerland)
7.6 Genentech, Inc. (USA)
7.6.1 Company profile
7.6.2 Representative Pediatric Drugs and Vaccines Product
7.6.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Genentech, Inc. (USA)
7.7 GlaxoSmithKline plc. (UK)
7.7.1 Company profile
7.7.2 Representative Pediatric Drugs and Vaccines Product
7.7.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc. (UK)
7.8 Janssen Biologics B.V. (USA)
7.8.1 Company profile
7.8.2 Representative Pediatric Drugs and Vaccines Product
7.8.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Janssen Biologics B.V. (USA)
7.9 Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.9.1 Company profile
7.9.2 Representative Pediatric Drugs and Vaccines Product
7.9.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.10 AstraZeneca Plc. (UK)
7.10.1 Company profile
7.10.2 Representative Pediatric Drugs and Vaccines Product
7.10.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca Plc. (UK)
7.11 Boehringer Ingelheim GmbH (Germany)
7.11.1 Company profile
7.11.2 Representative Pediatric Drugs and Vaccines Product
7.11.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH (Germany)
7.12 Bristol-Myers Squibb Company (USA)
7.12.1 Company profile
7.12.2 Representative Pediatric Drugs and Vaccines Product
7.12.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company (USA)
7.13 Allergan, Inc. (USA)
7.13.1 Company profile
7.13.2 Representative Pediatric Drugs and Vaccines Product
7.13.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Allergan, Inc. (USA)
7.14 Novartis AG (Switzerland)
7.14.1 Company profile
7.14.2 Representative Pediatric Drugs and Vaccines Product
7.14.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novartis AG (Switzerland)
7.15 Novo Nordisk A/S (Denmark)
7.15.1 Company profile
7.15.2 Representative Pediatric Drugs and Vaccines Product
7.15.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S (Denmark)
7.16 Pfizer, Inc. (USA)
7.17 Sanofi S.A (France)
7.18 Shionogi Inc. (USA)
7.19 Shire Pharmaceuticals Group Plc. (UK)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
8.1 Industry Chain of Pediatric Drugs and Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
9.1 Cost Structure Analysis of Pediatric Drugs and Vaccines
9.2 Raw Materials Cost Analysis of Pediatric Drugs and Vaccines
9.3 Labor Cost Analysis of Pediatric Drugs and Vaccines
9.4 Manufacturing Expenses Analysis of Pediatric Drugs and Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pediatric Drugs and Vaccines in This Report
1.2 Commercial Types of Pediatric Drugs and Vaccines
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Mumps
1.2.7 Others
1.3 Downstream Application of Pediatric Drugs and Vaccines
1.3.1 Newborn
1.3.2 Infant
1.3.3 Child
1.4 Development History of Pediatric Drugs and Vaccines
1.5 Market Status and Trend of Pediatric Drugs and Vaccines 2013-2023
1.5.1 Europe Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pediatric Drugs and Vaccines in Europe 2013-2017
2.2 Consumption Market of Pediatric Drugs and Vaccines in Europe by Regions
2.2.1 Consumption Volume of Pediatric Drugs and Vaccines in Europe by Regions
2.2.2 Revenue of Pediatric Drugs and Vaccines in Europe by Regions
2.3 Market Analysis of Pediatric Drugs and Vaccines in Europe by Regions
2.3.1 Market Analysis of Pediatric Drugs and Vaccines in Germany 2013-2017
2.3.2 Market Analysis of Pediatric Drugs and Vaccines in United Kingdom 2013-2017
2.3.3 Market Analysis of Pediatric Drugs and Vaccines in France 2013-2017
2.3.4 Market Analysis of Pediatric Drugs and Vaccines in Italy 2013-2017
2.3.5 Market Analysis of Pediatric Drugs and Vaccines in Spain 2013-2017
2.3.6 Market Analysis of Pediatric Drugs and Vaccines in Benelux 2013-2017
2.3.7 Market Analysis of Pediatric Drugs and Vaccines in Russia 2013-2017
2.4 Market Development Forecast of Pediatric Drugs and Vaccines in Europe 2018-2023
2.4.1 Market Development Forecast of Pediatric Drugs and Vaccines in Europe 2018-2023
2.4.2 Market Development Forecast of Pediatric Drugs and Vaccines by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pediatric Drugs and Vaccines in Europe by Types
3.1.2 Revenue of Pediatric Drugs and Vaccines in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pediatric Drugs and Vaccines in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pediatric Drugs and Vaccines in Europe by Downstream Industry
4.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Germany
4.2.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in France
4.2.4 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Italy
4.2.5 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Spain
4.2.6 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Benelux
4.2.7 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Russia
4.3 Market Forecast of Pediatric Drugs and Vaccines in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
5.1 Europe Economy Situation and Trend Overview
5.2 Pediatric Drugs and Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PEDIATRIC DRUGS AND VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pediatric Drugs and Vaccines in Europe by Major Players
6.2 Revenue of Pediatric Drugs and Vaccines in Europe by Major Players
6.3 Basic Information of Pediatric Drugs and Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pediatric Drugs and Vaccines Major Players
6.3.2 Employees and Revenue Level of Pediatric Drugs and Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PEDIATRIC DRUGS AND VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck & Co., Inc. (USA)
7.1.1 Company profile
7.1.2 Representative Pediatric Drugs and Vaccines Product
7.1.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. (USA)
7.2 Abbott Laboratories (USA)
7.2.1 Company profile
7.2.2 Representative Pediatric Drugs and Vaccines Product
7.2.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Abbott Laboratories (USA)
7.3 Amgen, Inc. (USA)
7.3.1 Company profile
7.3.2 Representative Pediatric Drugs and Vaccines Product
7.3.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Amgen, Inc. (USA)
7.4 Eli Lilly and Company (USA)
7.4.1 Company profile
7.4.2 Representative Pediatric Drugs and Vaccines Product
7.4.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly and Company (USA)
7.5 F. Hoffmann-La Roche Ltd (Switzerland)
7.5.1 Company profile
7.5.2 Representative Pediatric Drugs and Vaccines Product
7.5.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd (Switzerland)
7.6 Genentech, Inc. (USA)
7.6.1 Company profile
7.6.2 Representative Pediatric Drugs and Vaccines Product
7.6.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Genentech, Inc. (USA)
7.7 GlaxoSmithKline plc. (UK)
7.7.1 Company profile
7.7.2 Representative Pediatric Drugs and Vaccines Product
7.7.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc. (UK)
7.8 Janssen Biologics B.V. (USA)
7.8.1 Company profile
7.8.2 Representative Pediatric Drugs and Vaccines Product
7.8.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Janssen Biologics B.V. (USA)
7.9 Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.9.1 Company profile
7.9.2 Representative Pediatric Drugs and Vaccines Product
7.9.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.10 AstraZeneca Plc. (UK)
7.10.1 Company profile
7.10.2 Representative Pediatric Drugs and Vaccines Product
7.10.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca Plc. (UK)
7.11 Boehringer Ingelheim GmbH (Germany)
7.11.1 Company profile
7.11.2 Representative Pediatric Drugs and Vaccines Product
7.11.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH (Germany)
7.12 Bristol-Myers Squibb Company (USA)
7.12.1 Company profile
7.12.2 Representative Pediatric Drugs and Vaccines Product
7.12.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company (USA)
7.13 Allergan, Inc. (USA)
7.13.1 Company profile
7.13.2 Representative Pediatric Drugs and Vaccines Product
7.13.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Allergan, Inc. (USA)
7.14 Novartis AG (Switzerland)
7.14.1 Company profile
7.14.2 Representative Pediatric Drugs and Vaccines Product
7.14.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novartis AG (Switzerland)
7.15 Novo Nordisk A/S (Denmark)
7.15.1 Company profile
7.15.2 Representative Pediatric Drugs and Vaccines Product
7.15.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S (Denmark)
7.16 Pfizer, Inc. (USA)
7.17 Sanofi S.A (France)
7.18 Shionogi Inc. (USA)
7.19 Shire Pharmaceuticals Group Plc. (UK)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
8.1 Industry Chain of Pediatric Drugs and Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
9.1 Cost Structure Analysis of Pediatric Drugs and Vaccines
9.2 Raw Materials Cost Analysis of Pediatric Drugs and Vaccines
9.3 Labor Cost Analysis of Pediatric Drugs and Vaccines
9.4 Manufacturing Expenses Analysis of Pediatric Drugs and Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
